da Silva Cunha, T.T.; Silva, R.R.; Rodrigues, D.A.; de Sena Murteira Pinheiro, P.; Kronenberger, T.; Sant’Anna, C.M.R.; Noël, F.; Fraga, C.A.M.
Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases. Biomolecules 2022, 12, 1112.
https://doi.org/10.3390/biom12081112
AMA Style
da Silva Cunha TT, Silva RR, Rodrigues DA, de Sena Murteira Pinheiro P, Kronenberger T, Sant’Anna CMR, Noël F, Fraga CAM.
Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases. Biomolecules. 2022; 12(8):1112.
https://doi.org/10.3390/biom12081112
Chicago/Turabian Style
da Silva Cunha, Thayssa Tavares, Rafaela Ribeiro Silva, Daniel Alencar Rodrigues, Pedro de Sena Murteira Pinheiro, Thales Kronenberger, Carlos MaurÃcio R. Sant’Anna, François Noël, and Carlos Alberto Manssour Fraga.
2022. "Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases" Biomolecules 12, no. 8: 1112.
https://doi.org/10.3390/biom12081112
APA Style
da Silva Cunha, T. T., Silva, R. R., Rodrigues, D. A., de Sena Murteira Pinheiro, P., Kronenberger, T., Sant’Anna, C. M. R., Noël, F., & Fraga, C. A. M.
(2022). Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases. Biomolecules, 12(8), 1112.
https://doi.org/10.3390/biom12081112
